Oncolytics Biotech (ONCY) Misses Q3 EPS by 3c
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.